News Headlines Article

Senate Inquiry On Drug Prices Echoes Landmark Hearings Held 60 Years Ago
National Public Radio

On Tuesday, Kenneth Frazier, CEO of pharmaceutical giant Merck, is set to face senators who say drug costs are “sky-high” and “out of control.”

But Frazier doesn’t need new talking points. Sixty years ago, a different panel of senators grilled a different Merck boss about the same problem.

To a striking degree, the subjects likely to surface Tuesday — high drug prices and profits, limited price transparency, aggressive marketing, alleged patent abuse and mediocre “me too” drugs — are identical to the issues senators investigated decades ago, historical transcripts show.

Commands